BioCentury
ARTICLE | Company News

Phylos progress in Amgen deal

August 24, 2000 7:00 AM UTC

Under its drug discovery collaboration with AMGN, Phylos said it used its PROfusion peptide and protein selection technology to identify high-affinity binding agents to certain AMGN therapeutic target...